HANNAH NOLAN: Open Payments
NPI 1114547445 · MILLEDGEVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,447 in 76 payments from 16 companies in 2025. Trend: 2023 $1,117 · 2024 $1,469 · 2025 $1,447
Food & beverage: $1,447
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $287 |
| AstraZeneca Pharmaceuticals LP | 9 | $203 |
| Novo Nordisk Inc | 10 | $178 |
| Lilly USA, LLC | 7 | $117 |
| PFIZER INC. | 5 | $95 |
| Corcept Therapeutics | 5 | $93 |
| GlaxoSmithKline, LLC. | 5 | $87 |
| Amgen Inc. | 4 | $72 |
| Otsuka America Pharmaceutical, Inc. | 3 | $62 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $54 |
Products named: VRAYLAR, AIRSUPRA, Wegovy, MOUNJARO, Korlym, FARXIGA, OTEZLA, QULIPTA.
Industry payments across GA — which companies pay providers there.
